TORRENT PHARMACEUTICALS
|
The Current P/S Ratio of TORRENT PHARMACEUTICALS is 11.89.
| Share Price | ₹4,915.5 | Aug 10,2026 |
| Market Cap | ₹186,985.6 Cr | |
| Sales-TTM | ₹15,723.0 Cr | TTM-Consolidated Results |
| Price/Sales | 11.89x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹186,985.6 Cr] as on Aug 10,2026
(/) Sales [ ₹15,723.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 11.89x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '11.89 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS
PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 7.78x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 8.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 10.22x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 5.41x.
How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| TORRENT PHARMACEUTICALS | 15,723.0 | 11.89 | 186,985.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.82 | 468,530.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 19.56 | 219,675.0 |
| CIPLA LTD | 28,324.4 | 4.16 | 117,947.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.91 | 96,601.2 |
| MANKIND PHARMA LTD | 14,737.9 | 6.83 | 100,688.0 |
| LUPIN LTD | 29,966.6 | 3.47 | 104,021.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.12 | 111,790.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.71 | 94,707.2 |
| LAURUS LABS LTD | 7,269.6 | 13.87 | 100,822.0 |
| BIOCON LTD | 17,321.1 | 4.05 | 70,076.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.71x |
| Max industry PS | 19.56x |
| Median industry PS | 4.16x |
| Average industry PS | 7.40x |
You may also like the below Video Courses